Effectiveness, Implementation and Spillover Effects of a Culturally Adapted DPP in Spanish Primary Care Centers
Launched by UNIVERSITY OF THE BALEARIC ISLANDS · Mar 6, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Alongside type 2 diabetes (T2D), prediabetes prevalence is also rising, placing a significant burden on public health systems, individuals, and their families.
Promoting a healthy lifestyle that includes regular physical activity, a healthy diet, smoking cessation, and achieving and maintaining a healthy body weight can effectively prevent or delay T2D onset. Major diabetes prevention trials, such as the Diabetes Prevention Program (DPP) in the United States, have demonstrated that intensive lifestyle interventions can significantly reduce T2D risk in individuals with prediabetes.However, ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 years; body mass index (BMI) of ≥25 kg/m2 (≥23 kg/m2, if Asian); fasting plasma glucose (FPG) between 1010 and 125 mg/dL, or plasma glucose of 140 to 199 mg/dl measured 2 hours after a 75 g glucose load, or HbA1c between 5.7% and 6.4%, or with a documented history of gestational diabetes mellitus during a previous pregnancy.
- Exclusion Criteria:
- • Previous diagnosis of type 1 or type 2 diabetes; current use of antidiabetic medications; pregnancy at time of enrollment; terminal illness; institutionalization; dementia or significant cognitive impairment; major surgery or hospitalization in the previous 3 months; presence of any medical or psychological condition limiting participation; and concomitant active participation in another clinical trial.
Trial Officials
Miquel Bennasar-Veny, PhD
Principal Investigator
University of the Baleric Islands
About University Of The Balearic Islands
The University of the Balearic Islands (UIB) is a leading academic institution dedicated to advancing research and education in the health sciences. With a strong emphasis on innovation and interdisciplinary collaboration, UIB conducts clinical trials aimed at improving patient outcomes and enhancing healthcare practices. The university fosters an environment that promotes rigorous scientific inquiry and ethical standards, ensuring that studies are designed and executed with the highest level of integrity. Through its commitment to excellence in research, UIB contributes to the development of evidence-based medical knowledge and the training of future healthcare professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palma De Mallorca, Balearic Islands, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported